1 Product identity
Ingredient risk
No flagged ingredients
EstroPro
BrandUSANA→Other Combinations Tablet or Pill 12 ingredients DSLD #322316Net contents: 56 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-01-23
2 Ingredients (12)
IngredientGroupSafety
IsoflavonesIsoflavones—
Flaxseed ExtractFlax—
Microcrystalline CelluloseCellulose—
Starch, ModifiedStarch—
Vegetable Fatty AcidBlend (Fatty Acid or Fat/Oil Supplement)—
MaltodextrinMaltodextrin—
Sunflower Lecithinlecithin—
Palm OleinPalm oil—
Guar GumGuar—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Licorice Root — Limited Evidence
⚠ HYPERTENSION — pseudoaldosteronism
⚠ Hypokalemia
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID322316
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-01-23
6 More from USANA
View USANA Safety Scorecard → 7 products
Active CalciumBabyCare Prenatal Chelated MineralBabyCare Prenatal Mega AntioxidantMega AntioxidantPoly CProflavanol C 2007 Cite this page
Vancouver
Pkhakadze G. EstroPro — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://supplement.ge/products/dsld-322316/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG